METASTATIC NEUROENDOCRINE CARCINOMA
Clinical trials for METASTATIC NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Threat attack on aggressive neuroendocrine cancers
Disease control OngoingThis study is testing whether a combination of three drugs can help control advanced, aggressive neuroendocrine cancers that have worsened after one prior treatment. The drugs work together: one aims to block tumor growth directly, while the other two aim to help the patient's ow…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New combo therapy tested for Tough-to-Treat cancers that have returned
Disease control OngoingThis study is testing whether combining two existing drugs—nivolumab (an immunotherapy) and temozolomide (a chemotherapy)—can help control cancers that have come back or stopped responding to standard treatments. It is for adults with recurrent small-cell lung cancer or advanced …
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Feb 23, 2026 14:56 UTC